Tourette Syndrome Treatment Market Synthesis, Healthcare Reviews and Survey Reports 2020 - 2026

Tourette Syndrome Treatment Market recently Published Market Insights Reports with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed TOC on Tourette Syndrome Treatment Market".

Global Tourette Syndrome Treatment Market 2020: This Report provides highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on Markets and materials, capacities and on the changing structure of the Tourette Syndrome Treatment. The report also presents forecasts for Global Tourette Syndrome Treatment Market investments from 2020 till 2026.

Get Sample PDF Copy of Latest Research on Tourette Syndrome Treatment Market 2020:
https://www.marketinsightsreports.com/reports/04091971738/global-tourette-syndrome-treatment-market-size-status-and-forecast-2020-2026/inquiry?mode=54

Leading key Company's Covered for this Research are AstraZeneca,Boehringer Ingelheim International GmbH,Eli Lilly and Co.,Mylan NV,Otsuka Holdings Co. Ltd.,Sanofi S.A.,Pfizer Inc.,Sun Pharmaceutical Industries Ltd,Neurocrine Biosciences, Inc.,Novartis AG,Teva Pharmaceutical Industries Ltd.

In May 2019, H. Lundbeck A/S acquired US biotech company Abide Therapeutics Inc. The acquisition of Abide gives Lundbeck development project of ABX-1431, a first-in-class MAG Lipase inhibitor that is being explored in clinical trials as a first-of-its-kind compound for the treatment of Tourette Syndrome (exploratory phase IIa).

In August 2018, Emalex Biosciences, Inc. announced that it acquired Psyadon Pharmaceuticals and the exclusive rights to develop, register, and market ecopipam, a new chemical entity with orphan drug designation for the treatment of pediatric Tourette Syndrome in patients under 16 years of age.

In June 2018, Therapix Biosciences Ltd. sponsored 11th European Society for the Study of Tourette Syndrome (ESSTS) conference as part of the Company's strategy to develop a therapy for Tourette's patients and to support the Tourette's community.

Market segment by Type, the product can be split into
Antipsychotics
Non Antipsychotics
Market segment by Application, split into
Children
Adult

FEB 19, 2020 :Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Phase 2/3 ARTISTS 1 and Phase 3 ARTISTS 2 trials designed to evaluate deutetrabenazine compared to placebo for the treatment of tics in pediatric patients with moderate to severe Tourette Syndrome failed to meet the primary endpoint of reduction in motor and phonic tics as assessed by the Total Tic Score of the Yale Global Tic Severity Scale (YGTSS-TTS).
In the data received this week, the most commonly reported adverse event in the ARTISTS 1 and ARTISTS 2 studies were headache, somnolence and fatigue. In this population, no new safety signals were identified that were inconsistent with the known safety profile of deutetrabenazine.
"The results of the trials are disappointing, especially as there is such an unmet need for this community of pediatric patients," said Dr. Hafrun Fridriksdottir, Executive Vice President, Global R&D, at Teva. "As we assess a path forward, Teva is especially grateful to the investigators, patients and families who contributed to these studies for such an important patient population."
The studies were conducted in partnership between Teva and Nuvelution Pharma, Inc.
Deutetrabenazine was approved by the FDA as AUSTEDO� (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease in April 2017 and for tardive dyskinesia in adults in August 2017.

Browse Full Report: https://www.marketinsightsreports.com/reports/04091971738/global-tourette-syndrome-treatment-market-size-status-and-forecast-2020-2026?mode=54

Table of Content
1 Introduction of Global Tourette Syndrome Treatment Market
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 Global Tourette Syndrome Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Tourette Syndrome Treatment Market, By Deployment Model
5.1 Overview
6 Global Tourette Syndrome Treatment Market, By Solution
6.1 Overview
7 Global Tourette Syndrome Treatment Market, By Vertical
7.1 Overview
8 Global Tourette Syndrome Treatment Market, By Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East
9 Global Tourette Syndrome Treatment Market Competitive Landscape
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 Company Profiles
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
11 Appendix

Browse More Related Report;

Global Swedish Porphyria Treatment Market Size, Status And Forecast 2020-2026
https://www.marketinsightsreports.com/reports/04031948262/global-swedish-porphyria-treatment-market-size-status-and-forecast-2020-2026?node=54

Global Dermatophytosis Treatment Market Size, Status And Forecast 2020-2026
https://www.marketinsightsreports.com/reports/04031948233/global-dermatophytosis-treatment-market-size-status-and-forecast-2020-2026?mode=54

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

: contact@marketinsightsreports.com
Address : 4893, Pepper drive, Harrisburg ,NC 28075,United States
Address : 202, Business Square, Tilak Road, Pune, Maharashtra 411030
Contact Number : +1 (704) 266-3234

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.